title: Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.
abstract: Introducing anti-restenotic drug-based treatment modalities in femoropopliteal interventions is the potential revolutionizing reperfusion treatment of peripheral artery disease. Durability of recanalization procedures using drug-coated balloons (DCB) and drug-eluting stents (DES) yields in excellent mid-term and long-term technical and clinical outcomes and may be cost saving on the long term as compared to traditional treatment modalities such as plain old balloon angioplasty (POBA) and bare metal nitinol stent implantation. Drug-eluting bioresorbable scaffolds are another drug-based promising treatment option but are still investigational. In particular, DCB provide a novel method to locally deliver paclitaxel into the arterial wall without the need of a chronically implanted delivery system or even if those devices will be indicated, they can be delivered focally. Following the first positive pilot studies, two large pivotal trials have confirmed superiority of DCB over plain old balloon angioplasty (POBA) in the treatment of TASC II A and B femoropopliteal lesions. Even for more complex femoropopliteal lesions such as long lesions and instent restenosis, single center studies and small randomized studies have shown promising mid-term technical and clinical results. For DES, follow-up data for the only commercially available device are now presented up to 5 years with excellent clinical outcome regarding freedom from target lesion revascularization and improvement of walking capacity. This review article summarizes the current knowledge and perspectives of drug-based endovascular treatment modalities in femoropopliteal interventions and discusses still unresolved needs.
authors.affiliation: Angiology Division, University Heart Center Freiburg - Bad Krozingen, Südring 15, D-79189, Bad Krozingen, Baden-Württemberg, Germany, Thomas.Zeller@universitaets-herzzentrum.de.
authors.forename: Thomas
authors.initials: T
authors.lastname: Zeller
authors.forename: Aljoscha
authors.initials: A
authors.lastname: Rastan
authors.forename: Roland
authors.initials: R
authors.lastname: Macharzina
authors.forename: Ulrich
authors.initials: U
authors.lastname: Beschorner
authors.forename: Elias
authors.initials: E
authors.lastname: Noory
mesh_terms: D020341:Absorbable Implants / Q000639:trends; D000800:Angioplasty, Balloon / Q000379:methods / Q000639:trends; D001783:Blood Flow Velocity; D002317:Cardiovascular Agents / Q000627:therapeutic use; D020099:Coated Materials, Biocompatible; D054855:Drug-Eluting Stents / Q000639:trends; D005263:Femoral Artery / Q000503:physiopathology*; D006801:Humans; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D011150:Popliteal Artery / Q000503:physiopathology*; D014654:Vascular Patency
chemical_list: D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible